Aquapharm Chemicals Profile
Key Indicators
- Authorised Capital ₹ 5.01 Cr
as on 22-06-2024
- Paid Up Capital ₹ 2.12 Cr
as on 22-06-2024
- Company Age 50 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 274.50 Cr
as on 22-06-2024
- Satisfied Charges ₹ 314.43 Cr
as on 22-06-2024
- Revenue 0.52%
(FY 2023)
- Profit -26.07%
(FY 2023)
- Ebitda -31.03%
(FY 2023)
- Net Worth 11.96%
(FY 2023)
- Total Assets -8.16%
(FY 2023)
About Aquapharm Chemicals
The Corporate was formerly known as Vikram Ion Exchangers Pvt Ltd. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.01 Cr and a paid-up capital of Rs 2.12 Cr.
The company currently has active open charges totaling ₹274.50 Cr. The company has closed loans amounting to ₹314.43 Cr, as per Ministry of Corporate Affairs (MCA) records.
Gopal Rathi, Subhasis Mitra, and Kaushik Roy serve as directors at the Company.
- CIN/LLPIN
U24231MH1974PTC017243
- Company No.
017243
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Mar 1974
- Date of AGM
17 Aug 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Aquapharm Chemicals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kaushik Roy  | Additional Director | 31-Jan-2024 | Current |
| Gopal Rathi | Additional Director | 31-Jan-2024 | Current |
| Subhasis Mitra | Additional Director | 31-Jan-2024 | Current |
Financial Performance and Corporate Structure Insights of Aquapharm Chemicals.
Aquapharm Chemicals Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 0.52% increase. The company also saw a substantial fall in profitability, with a 26.07% decrease in profit. The company's net worth Soared by an impressive increase of 11.96%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aquapharm Chemicals?
In 2023, Aquapharm Chemicals had a promoter holding of 100.01%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 17 Jul 2020 | ₹38.50 Cr | Open |
Corporation Bank Creation Date: 23 Oct 2002 | ₹236.00 Cr | Open |
Citi Bank N.A. Creation Date: 02 Jan 2020 | ₹19.00 Cr | Satisfied |
How Many Employees Work at Aquapharm Chemicals?
Aquapharm Chemicals has a workforce of 334 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aquapharm Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aquapharm Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
